IMMULAB: A phase II trial of immunotherapy with pembrolizumab in combination with local ablation for patients with early-stage hepatocellular carcinoma (HCC)

A Vogel, O Waidmann, T Muller, GM Siegler (Co-author), TO Goetze, EN De Toni, MA Gonzalez-Carmona, G Hausner, M Geissler, LF von Weikersthal, AMR Kestler, F Finkelmeier, M Kleiss, JU Marquardt, A Teufel, J Klagges, R Eickhoff, SE Al-Batran, AL Saborowski

Research output: Contribution to journalOriginal Articlepeer-review

4 Citations (Web of Science)
Original languageEnglish
Pages (from-to)555
Number of pages1
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume41
DOIs
Publication statusPublished - 2023

Cite this